1. Home
  2. WS vs ANAB Comparison

WS vs ANAB Comparison

Compare WS & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

HOLD

Current Price

$31.80

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$64.71

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
ANAB
Founded
1955
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
WS
ANAB
Price
$31.80
$64.71
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$47.00
$72.60
AVG Volume (30 Days)
210.4K
454.5K
Earning Date
03-25-2026
03-03-2026
Dividend Yield
2.02%
N/A
EPS Growth
N/A
91.02
EPS
1.10
N/A
Revenue
$3,093,300,000.00
$234,603,000.00
Revenue This Year
$21.33
N/A
Revenue Next Year
$3.41
$43.04
P/E Ratio
$28.78
N/A
Revenue Growth
N/A
157.01
52 Week Low
$21.30
$15.40
52 Week High
$49.17
$68.39

Technical Indicators

Market Signals
Indicator
WS
ANAB
Relative Strength Index (RSI) 21.49 62.82
Support Level $29.63 $43.67
Resistance Level $33.09 N/A
Average True Range (ATR) 1.47 3.94
MACD -0.89 0.58
Stochastic Oscillator 2.42 75.49

Price Performance

Historical Comparison
WS
ANAB

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: